Chitosan microspheres for intrapulmonary administration of moxifloxacin: Interaction with biomembrane models and in vitro permeation studies

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 68, Issue 2, 2008, Pages 235-244

  Ventura, Cinzia A ^a   Tommasini, Silvana ^a   Crupi, Emanuela ^a   Giannone, Ignazio ^b   Cardile, Venera ^b   Musumeci, Teresa ^b   Puglisi, Giovanni ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Biomembrane interaction; Calu 3 cell monolayer; Chitosan microparticles; In vitro permeation; Moxifloxacin

Indexed keywords

CHITOSAN; DIPALMITOYLPHOSPHATIDYLCHOLINE; GLUTARALDEHYDE; LIPOSOME; MICROSPHERE; MOXIFLOXACIN;

ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG FORMULATION; DRUG PENETRATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID VESICLE; MEMBRANE PERMEABILITY; SUSTAINED DRUG RELEASE;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE; CELL MEMBRANE PERMEABILITY; CHITOSAN; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; QUINOLINES;

EID: 37849015123     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.05.011     Document Type: Article

References (27)

1. Sanjar S., and Matthews S. Treating systemic diseases via the lung. J. Aerosol. Med. 14 (2001) S51-S58
2. Gonda I. Drugs administered directly into the respiratory tract: modeling of the duration of effective drug levels. J. Pharm. Sci. 77 (1988) 340-346
3. Tharanathan R.N., and Kittur F.S. Chitin-the undisputed biomolecule of great potential. Crit. Rev. Food Sci. Nutr. 43 (2003) 61-87
4. Varum K.M., Myhr M.M., Hjerde R.J.N., and Smidsrod O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr. Res. 299 (1997) 99-101
5. Konstan M.W., Chen P.W., Sherman J.M., Thomassen M.J., Wood R.E., and Boat T.F. Human lung lysozyme: sources and properties. Am. Rev. Respir. Dis. 123 (1981) 120
6. Lehr C.M., Bouwstra J.A., Schacht E.H., and Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78 (1992) 43-48
7. Vasir J.K., Tambwekar K., and Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int. J. Pharm. 255 (2003) 13-32
8. Illum L., Farraj N.F., and Davis S.S. Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res. 11 (1994) 1186-1189
9. Edlund C., Beyer G., Hiemer-Bau M., Ziege S., Lode H., and Nord C.E. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand. J. Infect. Dis. 32 (2000) 81-85
10. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 234 (1959) 466-468
11. Agu R.U., Jorissen M., Willems T., Augustijns P., Kinget R., and Verbeke N. In-vitro nasal drug delivery studies: comparison of derivatised, fibrillar and polymerised collagen matrix-based human nasal primary culture systems for nasal drug delivery studies. J. Pharm. Pharmacol. 53 (2001) 1447-1456
12. He P., Davis S.D., and Illum L. Chitosan microspheres prepared by spray drying. Int. J. Pharm. 187 (1999) 53-65
13. Alpar H.O., Somavarapu S., Atuah K.N., and Bramwell V.W. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Adv. Drug Deliv. Rev. 57 (2005) 411-430
14. Neto C.G.T., Giacometti J.A., Job A.E., Ferreira F.C., Fonseca J.L.C., and Pereira M.R. Thermal analysis of chitosan based networks. Carbohyd. Polym. 62 (2005) 97-103
15. Giammona G., Pitarresi G., Tomarchio V., Cavallaro G., and Mineo M. Crosslinked α,β-polyasparthydrazide hydrogels: effect of crosslinking degree and loading method on cytarabine release rate. J. Control. Rel. 41 (1996) 195-203
16. Jameela S.R., and Jayakrishnan A. Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vitro degradation of microspheres in rat muscle. Biomaterials 16 (1995) 769-775
17. Estep T.N., Mountcastle D.B., Biltonen R.L., and Thompson T.E. Thermal behaviour of synthetic sphingomyelin-cholesterol dispersion. Biochemistry 18 (1978) 2112-2117
18. Jain M.K. Properties of bilayer. In: Jain M.K. (Ed). Introduction to Biological Membranes (1988), John Wiley & Sons Inc., New York 86-121
19. Jain M.K. Order and dynamics in bilayers and solute in bilayers. In: Jain M.K. (Ed). Introduction to Biological Membranes (1988), John Wiley & Sons Inc., New York 122-146
20. Fresta M., Guccione S., Beccari A.R., Furneri P.M., and Puglisi G. Combining Molecular modelling with experimental methodologies: mechanism of membrane permeation and accumulation of ofloxacin. Bioorg. Med. Chem. 10 (2002) 3871-3889
21. Fang N., Chan V., Mao H.Q., and Leong K.W. Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules 2 (2001) 1161-1168
22. Fogh J., and Trempe G. In: Fogh J. (Ed). Human Tumor Cells In Vitro (1975), Plenum Press, New York 115-159
23. Shen B.Q., Finkbeiner W.E., Wine J.J., Mrsny R.J., and Widdicombe J.H. Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl-secretion. Am. J. Physiol. 266 (1994) L493-L501
24. Foster K.A., Yazdanian M., and Audus K.L. Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J. Pharm. Pharmacol. 53 (2001) 57-66
25. Geys J., Coenegrachts L., Vercammen J., Engelborghs Y., Nemmara A., Nemery B., and Hoet P.H.M. In vitro study of the pulmonary translocation of nanoparticles. A preliminary study. Toxicol. Lett. 160 (2006) 218-226
26. Huang M., Khor E., and Lim L.Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm. Res. 21 (2004) 344-353
27. Artusson P., Lindmark T., Davis S.S., and Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res. 11 (1994) 1358-1361